Innovators are at the very heart of Europe’s new industrial strategy which charts a course for it transition towards digital leadership. Europe’s industrial strengths include high quality research, and a vibrant start-up ecosystem and a mature infrastructure, key elements of the cybersecurity landscape. Cybersecurity is a top priority in Europe with the EU investing in research and innovation since the early 1990s. A rich array of large and small businesses, universities and research organisations ensure a there is a constant flow of new results, services and skills emerging.
The 2nd General Assembly of Caramel Project took place in Aveiro, Portugal at the Fundação Engenheiro António Pascoal from 29 – 30 January 2020. In this session, the entire CARAMEL consortium, formed by academic and industry partners as well as the Project Coordinator and Technical Manager participated reviewing the actions carried out and defining the next steps to achieve the goals of CARAMEL Project.
Cyberwatching.eu representatives were recently active in various initiatives across Europe to spread the word about the project’ s outcomes across Europe, establish synergies with other relevant H2020 initiatives and engage with the European cybersecurity community.
Technological drivers, such as IoT, blockchains and AI, are raising some challenges that need to be addressed through the definition of a common legal umbrella to regulate a future data-driven society. The current main EU legal instruments in the cybersecurity and data-protection fields, such as NIS Directive, GDPR and the EU Cybersecurity Act, must deal with incessant technological evolution.
CyberSolace, has added a new niche capability to its portfolio of cybersecurity consulting services in the form of Crypto-Currency traceability services in Cybercrime cases. Especially in relation to ransomware attacks and extorted funds tracing and recoverability.
https://corvusglobalevents.com/conferenceInfo.php?ref=PHARMA-SUPPLY-CHAIN--SECURITY-WORLD-2020The rising tide of counterfeit medicines are turning into a serious concern around the world, and have progressively been showing up through the real pharmaceutical supply chain, including community and online drug stores. Counterfeit drugs are not only a global public health risk, but also harm the quality of the product, the integrity of the brand, the economy and even national security. We require both countrywide and industry-level participation, and in addition public and private sector coordinated effort, to identify and definitively battle counterfeiters.